Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.
about
The management of glaucoma and intraocular hypertension: current approaches and recent advancesGlaucoma: a review of adjunctive therapy and new management strategies.Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: a patient-use studyRecent advances in pharmacotherapy of glaucomaBimatoprost in the treatment of eyelash hypotrichosisEyelash growth from application of bimatoprost in gel suspension to the base of the eyelashes.Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionA randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprostNew glaucoma medications in the geriatric population: efficacy and safety.Prostamides (prostaglandin-ethanolamides) and their pharmacology.Clinical options for the reduction of elevated intraocular pressureA randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension.Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension.Effects of the combination of bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomised clinical trialPatterns of opioid analgesic prescription among patients with osteoarthritis.In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study.The side effects of the prostaglandin analogues.Predictive value of the efficacy of glaucoma medications in regulatory trials: Phase I-III to post-marketing studies.Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model.First-line treatment for elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension: focus on bimatoprostBimatoprost - a review.Comparison of the effects of bimatoprost and timolol on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: A prospective, open-label, randomized, two-arm, parallel-group studyBimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patientsBimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies.Emerging drugs for ocular hypertension.Tafluprost for glaucoma.Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution.Does the intraocular pressure-lowering effect of prostaglandin analogues continue over the long term?Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications.A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure.The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients.The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.Effects of an unfixed combination of latanoprost and pilocarpine on the intraocular pressure and pupil size of normal dogs.Ocular Redness Measured with the Keratograph 5M in Patients Using Anti-Glaucoma Eye Drops.Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis.Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation.Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting.
P2860
Q22305849-3A434582-D095-4196-A4D0-90762F0BB4DCQ33307040-7EA70325-71B4-46B7-9031-E6858E6C94A1Q33343120-503A04CC-0C0F-488A-B69A-959D537A1B70Q33521178-2CA295F5-0A74-4389-8EAE-9C812D5309F4Q33819865-558D8A29-B0F6-422E-8D19-7BF589FA40D6Q33828843-BB48A23F-572F-4887-8FE5-A02E39C1D245Q34043309-1A69526F-4B38-43D4-87D5-D3A1AF52E5EFQ34399842-CF9462C1-D865-4AD4-8EA9-6A58568ED63BQ34655477-A85D52EC-E0CC-443A-A89D-D3D6BA881816Q34667670-1730F1CB-DC5F-4B6A-BA8F-0E433BEED746Q34708267-39F55689-D2A5-44CF-BB6D-F412FEE9E04DQ35590426-37A65ADB-0EA6-4B37-9128-D300FABC6A72Q35592196-DF203115-074B-4E4C-85D9-6AC29910A181Q35593148-D438848D-0AE3-42CC-AA52-07F3C92C4057Q35775628-15C0E528-662D-4EF7-B2CB-59597CA110D4Q35904919-22C14DDC-F37B-476F-BB20-3C3C106C19CCQ36689066-8261D07C-96FC-4CB6-B54F-6EB138C3DE6BQ36856440-8F942CC8-0426-44E1-AA56-E0D216F2C5E7Q36920000-B0D2E824-E9CE-4694-9259-BE96C484F639Q37239287-02368B32-4870-4F18-A064-5971E112D2AEQ37623833-CD9776D7-FA8F-4828-90DA-26DC2A0EBAF3Q37660978-5A4BF100-00AC-4C18-8F6B-833FB0F510ADQ37697869-CE128960-51B4-4386-BEA0-E8FC1682A46AQ37729889-6E626771-AB25-4C5C-9FF0-0A1F0854D2FFQ37847182-F5D1AE94-A5BE-4CCA-BE38-C78FBFC3164DQ37931967-8F156C44-131A-4C26-96C6-3314AF8B6CF8Q39458214-BCD44457-4543-408A-8CB0-76356BCBBD0AQ39506959-7FC5B2C8-1A16-4B55-8980-07311066EBCEQ42280470-D09BBA01-A90E-4D2B-9EFD-282B37365ADBQ45462727-AE1C8679-37D4-4923-9C6E-AB43A444724AQ46525724-BFBB1159-EE3F-4FDC-B6D6-0A58E235451CQ46846456-6B337844-5098-4B9F-8425-D3DBC005E116Q47345982-8FD220A5-5E36-4865-B856-3CE2004F6D42Q49963780-E5694C4E-945C-4440-A9A2-339D7FF307DCQ50348514-3C47C47E-BF9E-4822-BA6D-D3429335A0CAQ52143379-F134C943-ADE6-40F1-8F7D-C7A34A974F05Q52995234-CA62680A-4C77-411C-BB66-12BFA78F3B9E
P2860
Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Six-month comparison of bimato ...... elevated intraocular pressure.
@en
Six-month comparison of bimato ...... elevated intraocular pressure.
@nl
type
label
Six-month comparison of bimato ...... elevated intraocular pressure.
@en
Six-month comparison of bimato ...... elevated intraocular pressure.
@nl
prefLabel
Six-month comparison of bimato ...... elevated intraocular pressure.
@en
Six-month comparison of bimato ...... elevated intraocular pressure.
@nl
P2093
P1476
Six-month comparison of bimato ...... elevated intraocular pressure.
@en
P2093
Bimatoprost Study Groups 1 and 2
M Sherwood
P304
P356
10.1016/S0039-6257(01)00219-3
P478
45 Suppl 4
P577
2001-05-01T00:00:00Z